Publication
Whole-exome sequencing in patients with clinical diagnosis of Familial Hypercholesterolaemia
| dc.contributor.author | Alves, A.C. | |
| dc.contributor.author | Bourbon, M. | |
| dc.date.accessioned | 2012-07-10T12:45:33Z | |
| dc.date.available | 2012-07-10T12:45:33Z | |
| dc.date.issued | 2012-06 | |
| dc.description.abstract | Familial hypercholesterolemia (FH) results from defects in the hepatic uptake and degradation of LDL via the LDL-receptor pathway, common caused by a loss-of-function mutation in the LDLR receptor gene (LDLR), by mutations in the gene enconding apolipoprotein B (APOB) or rare dominant gain-of-function mutations in a member of the proprotein convertase family (PCSK9). However, mutations which encodes a protein required for clathrin-mediated internalization of the LDLR (LDLRAP1) by the liver, has also been described as a recessive form of FH. The presence of mutations in other genes (CYP7A1, enzyme that catalyses the first step in the hepatic catabolism of cholesterol, and SREBP-2, a transcription factor that bind to the sterol regulatory element ) have been described, but these are very rare causes of hypercholesterolaemia. In the Portuguese FH Study only 40% of clinical FH patients have an identifiable mutation so, other mutations in these genes or other gene defects must exist to explain the cause of hypercholesterolemia in the remaining families. Next-generation high-throughput DNA sequencing techniques are opening fascinating opportunities in life sciences. The next-generation sequencing (NGS) technologies offer novel and rapid ways for genome-wide characterisation and profiling of mRNAs, small RNAs, transcription factor regions, structure of chromatin and DNA methylation patterns, microbiology and metagenomics. | por |
| dc.identifier.uri | http://hdl.handle.net/10400.18/896 | |
| dc.language.iso | eng | por |
| dc.publisher | Instituto Nacional de Saúde Doutor Ricardo Jorge, IP | por |
| dc.subject | Doenças Cardio e Cérebro-vasculares | por |
| dc.title | Whole-exome sequencing in patients with clinical diagnosis of Familial Hypercholesterolaemia | por |
| dc.type | conference object | |
| dspace.entity.type | Publication | |
| oaire.citation.conferencePlace | Nürnberg, Germany | por |
| oaire.citation.title | European Human Genetics Conference, 22-26 June, 2012 | por |
| rcaap.rights | embargoedAccess | por |
| rcaap.type | conferenceObject | por |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Whole-exome sequencing in patients with clinical.pdf
- Size:
- 1.09 MB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: